Clinical trials are still written like manuscripts, and that’s slowing everything down.
From site activation delays to missed patient matches, the lack of machine-readable protocols is holding back progress. Dr. Jose Galvez explains why metadata-tagged, computable protocols are the future, and what it will take to get there.